Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

How to Reconstitute CJC-1295: Our Official Lab Procedure

You’ve made a critical investment in your research. In your hands is a vial of high-purity, lyophilized peptide—a delicate chain of amino acids synthesized with absolute precision. At Real Peptides, our team is obsessed with this part of the process, ensuring

You’ve made a critical investment in your research. In your hands is a vial of high-purity, lyophilized peptide—a delicate chain of amino acids synthesized with absolute precision. At Real Peptides, our team is obsessed with this part of the process, ensuring every batch we produce meets the most stringent quality standards. But we’ve also seen where even the most promising research can falter. It’s not during synthesis; it’s in the next, seemingly simple step: reconstitution.

Let's be honest, transforming that stable, chalky powder into a viable, sterile liquid solution is where the integrity of your entire project is on the line. One small misstep, one moment of carelessness, can introduce contamination, alter the peptide’s structure, or create an incorrect concentration, rendering your data unreliable. This isn’t just about adding water to a powder. It’s a meticulous lab procedure that demands respect. Our experience shows that mastering this process is a non-negotiable element for achieving reproducible results. So, we're pulling back the curtain on our exact, in-house protocol for how to reconstitute CJC-1295, ensuring you can proceed with the same confidence we have in our products.

What Exactly Is Reconstitution and Why Is It So Critical?

First, let's talk about why your peptide arrives as a powder in the first place. That delicate, white puck at the bottom of the vial is the result of lyophilization, which is essentially a sophisticated freeze-drying process. We do this for one reason: stability. In their liquid state, complex molecules like peptides are vulnerable to degradation from temperature fluctuations and microbial growth. Lyophilization removes the water, locking the peptide into a stable, solid state that preserves its structure for shipping and storage. It's an incredibly effective method.

Reconstitution is the process of reversing that. You're carefully reintroducing a sterile liquid (a diluent) to bring the peptide back into a solution that can be accurately measured and used in your research. Simple, right?

Not exactly. This is where the variables come into play. The type of diluent you use, your sterile technique, and even the way you mix the solution can have a profound impact. A catastrophic error here isn't just a minor setback; it can completely invalidate your work. Think about it: if the peptide is damaged or the concentration is off by 20%, every subsequent data point is built on a flawed foundation. We can't stress this enough: the precision you apply during reconstitution is just as important as the purity of the peptide you start with. It's the bridge between a high-quality product and high-quality data.

Gathering Your Essential Lab Supplies

Before you even think about touching a vial, you need to set up your workspace like a professional. A clean, organized environment minimizes the risk of contamination and error. Our team has a standard checklist for this procedure, and we recommend you adopt a similar one. Nothing gets started until everything is accounted for.

Here’s what you’ll need:

Your Vial of Lyophilized CJC-1295: This is your primary material. Whether you're working with a standalone compound like our CJC-1295 NO DAC or a blend such as our CJC-1295 / Ipamorelin, the principles are the same. The vial is sealed under vacuum, so handle it with care.

Bacteriostatic Water: This is your diluent. We exclusively recommend using high-quality Bacteriostatic Water for reconstitution. It's sterile water that contains 0.9% benzyl alcohol, a bacteriostatic agent that inhibits bacterial growth. This is absolutely critical if you plan on drawing from the vial multiple times over days or weeks.

Syringes: You'll need at least one syringe, typically a 1mL or 3mL syringe with a needle (around 21-23 gauge is standard), for drawing the bacteriostatic water and adding it to your peptide vial. You will need a separate, smaller syringe (like an insulin syringe marked in mcg or IU) for accurately measuring your final doses.

Alcohol Prep Pads: Sterility is paramount. You'll need several of these to wipe the rubber stoppers of both your peptide vial and the bacteriostatic water vial.

Sterile Gloves: Never handle your research materials with bare hands. It's a fundamental rule of good laboratory practice.

A Clean, Well-Lit Workspace: A dedicated, uncluttered surface that has been wiped down with a disinfectant is essential.

Having everything laid out and within reach before you start prevents scrambling mid-process, which is when mistakes often happen. This setup is the foundation of a successful reconstitution.

Before You Begin: Critical Pre-Reconstitution Checks

Don't rush it. We've seen researchers, eager to get started, skip these preliminary steps, and it's a recipe for problems. Patience here pays dividends.

First, if your peptide vial has been stored in the refrigerator (as it should be), take it out and allow it to come to room temperature. This usually takes about 20-30 minutes. Why? Introducing cold bacteriostatic water into a cold, vacuum-sealed vial can cause condensation and pressure changes that you don't want. Letting them equalize in temperature first makes for a smoother process.

Next, perform a visual inspection. Look at the vial of CJC-1295. Is the rubber stopper secure? Is the cap intact? Are there any cracks in the glass? The lyophilized powder should typically look like a solid, white, compacted disc or powder at the bottom. If you see anything that looks discolored, moist, or otherwise compromised, do not proceed.

Now, it’s time to sanitize. This is a non-negotiable step. Put on your sterile gloves. Take an alcohol prep pad and vigorously scrub the rubber stopper of the bacteriostatic water vial. Then, use a fresh alcohol pad to do the same for your CJC-1295 vial. Let them air dry for a moment. This simple action is one of your primary defenses against bacterial contamination that could ruin your peptide and your research.

The Step-by-Step Reconstitution Protocol: Our Method

Alright, you're prepared. Your station is clean, and your materials are ready. Now, we get into the meticulous part. Follow these steps precisely for a perfect reconstitution every time. This is the exact procedure our own scientists use.

Step 1: Calculate Your Diluent Volume

This is where math matters. You need to decide on your final concentration. We've found that a concentration of 1mg/mL (or 1000mcg/mL) is often easy to work with for dosing calculations. Let’s use a common example: a 2mg vial of CJC-1295.

Goal: Reconstitute a 2mg vial of peptide.

Desired Concentration: 1mg per 1mL.

Calculation: To get 1mg/mL from a 2mg vial, you need to add 2mL of bacteriostatic water.

This means that every 1mL of solution you draw will contain 1mg of peptide. If you need a 500mcg dose, you would draw 0.5mL. If you want a more concentrated solution, you could add only 1mL of bacteriostatic water to the 2mg vial. This would give you a concentration of 2mg/mL, meaning a 500mcg dose would be a smaller 0.25mL volume. The key is to be consistent and to record your dilution ratio carefully.

Step 2: Prepare the Bacteriostatic Water

Take your larger syringe (the 1mL or 3mL one). Uncap the needle. Draw back the plunger to the volume you calculated in Step 1 (e.g., 2mL). This fills the syringe with air. Now, with the bacteriostatic water vial standing upright on your clean surface, insert the needle through the sanitized rubber stopper. Inject the air from the syringe into the vial. This equalizes the pressure and makes it much easier to draw the liquid out. Then, invert the vial and slowly pull back the plunger to draw out exactly 2mL of water.

Step 3: Introduce the Water to the Peptide

This is the most delicate part of the entire process. Peptides are long, fragile chains of amino acids. A forceful stream of water can physically break them apart, a process called shearing. You must avoid this.

Take the syringe filled with bacteriostatic water and carefully insert the needle through the sanitized stopper of the CJC-1295 vial. Angle the needle so that it's touching the inside wall of the glass vial. Now, slowly—and we mean slowly—depress the plunger. Let the water trickle down the side of the glass and pool gently over the lyophilized powder. Do not, under any circumstances, squirt the water directly onto the powder itself. This gentle introduction allows the powder to dissolve without being subjected to damaging physical force.

Step 4: Gently Mix the Solution

Once all the water has been added, remove the syringe. Now, you need to ensure the peptide fully dissolves. The cardinal rule here is: swirl, don't shake. Shaking a vial of peptides is another way to destroy them. The agitation and creation of bubbles can denature the proteins, rendering them useless.

Instead, hold the vial between your thumb and forefinger and gently roll or swirl it. You can let it sit for a few minutes to dissolve on its own and then give it a few more gentle swirls. The process should be calm and patient. It's a finesse move, not a brute-force one.

Step 5: Inspect the Final Solution

Once the powder is fully dissolved, hold the vial up to a light source. A properly reconstituted peptide solution should be perfectly clear. Crystal clear. There should be no discoloration, floating particles, or cloudiness. If your solution appears cloudy or has particulates, it may indicate a problem with the peptide itself or a contamination issue. Do not use it. When you source from a reputable supplier like Real Peptides, this is rarely an issue, but it's a critical final quality check nonetheless.

Reconstitution Solvents: A Comparison

While our team stands firmly behind bacteriostatic water for most applications, it's important for researchers to understand the options. The diluent you choose has a direct impact on the stability and sterility of your final solution. Here's a breakdown of the common choices.

Bacteriostatic Water

Standard for most peptides like CJC-1295

~28 days

Contains 0.9% benzyl alcohol to prevent bacterial growth.

The Gold Standard. Ensures sterility for multi-use vials, making it ideal for research protocols.

Sterile Water

Single-use applications, immediate use

< 24 hours

Pure H2O, no preservatives. Suitable if the entire vial will be used at once.

Risky for multi-use vials due to the high potential for contamination after the first puncture.

Acetic Acid (0.6%)

For specific, less soluble peptides (e.g., some IGFs)

Varies

Can improve solubility for notoriously difficult-to-dissolve peptide sequences.

Not recommended for CJC-1295. It's unnecessary and can alter the solution's pH, potentially affecting stability.

For CJC-1295 and the vast majority of peptides you'll find in our full peptide collection, bacteriostatic water is the unequivocal best choice. It provides the perfect balance of solvency and long-term sterility for a typical research timeline.

Common Mistakes We See (And How to Avoid Them)

Over the years, our support team has heard it all. We've compiled a list of the most frequent—and preventable—errors that researchers make during reconstitution. Avoiding these is key to protecting your investment.

Shaking the Vial: We've said it before, but it bears repeating. It is the single most destructive thing you can do to a reconstituted peptide. The mechanical stress will literally tear the molecule apart. Always swirl gently.

Using the Wrong Diluent: We once heard from a researcher who used tap water. It's a catastrophic mistake. Tap water is not sterile and contains minerals and impurities that can react with the peptide. Only use the appropriate laboratory-grade diluent.

Incorrect Calculations: Double-check your math. Then check it again. An error in calculating your diluent volume will throw off every single dose you measure. Write it down, and have a clear plan before you start.

Poor Sterile Technique: Forgetting to swab the vial stoppers is a common oversight. This is how bacteria from the environment get introduced into your supposedly sterile solution. Be meticulous.

Ignoring Temperature: Reconstituting a freezing-cold vial can lead to problems. Always let it acclimate to room temperature first.

Improper Storage: Once reconstituted, the peptide is vulnerable. Leaving it out on the lab bench at room temperature for hours will initiate degradation. It must be stored in the refrigerator immediately after reconstitution and between uses.

Avoiding these pitfalls isn't hard. It just requires a disciplined, process-oriented approach. That’s the reality. It all comes down to diligence.

Storage and Handling of Reconstituted CJC-1295

Your job isn't done once the powder is dissolved. Proper storage is essential to maintain the peptide's potency for the duration of its use.

Refrigeration is mandatory. The ideal temperature range is between 2°C and 8°C (36°F and 46°F). This slows down the chemical degradation of the peptide in its aqueous state. Your lab or home refrigerator is perfect for this.

Protect it from light. Peptides can be sensitive to UV light. Storing the vial in its original box or in a dark part of the refrigerator provides an extra layer of protection.

One thing you should never do is freeze a reconstituted peptide. While the lyophilized powder is happy in the freezer, freezing the liquid solution is destructive. As the water freezes, it forms ice crystals that have sharp, jagged edges at a microscopic level. These crystals can physically shear and destroy the delicate peptide chains. You go through all the trouble of gently reconstituting it only to shred it in the freezer. Don't do it.

When reconstituted with bacteriostatic water and stored correctly, a vial of CJC-1295 is typically stable for research use for at least 4 weeks. This gives you a reasonable window to conduct your experiments without worrying about a significant loss of potency.

Following these steps ensures that the high-purity peptide you purchased remains a high-purity solution from the first dose to the last. It’s about honoring the integrity of the material and the integrity of your research. When your work requires this level of precision, it’s time to Discover Premium Peptides for Research that you can trust from start to finish.

Frequently Asked Questions

This is completely normal. Lyophilized peptides are very light and compact. A 2mg or 5mg dose is a tiny amount of material, so the vial will appear mostly empty. The product is dosed by weight, not volume.

You can, but only if you plan to use the entire contents of the vial immediately in a single application. Sterile water has no antibacterial agent, so once opened, it’s highly susceptible to contamination. For multi-use vials, we strongly recommend bacteriostatic water.

A properly reconstituted CJC-1295 solution should be crystal clear. If it’s cloudy or contains visible particles, it could indicate contamination or a problem with the product. We advise against using it.

It should dissolve quite quickly, usually within a minute or two of gentle swirling. If it’s taking a very long time, you can let it sit in the refrigerator for 20-30 minutes and then swirl it again.

Shaking creates forceful agitation and bubbles, which can denature the peptide. This means the complex, folded structure of the amino acid chain is broken, rendering it biologically inactive and useless for research.

No, the total potency of the vial remains the same regardless of the dilution. Adding more or less water only changes the concentration (e.g., mg per mL). It’s crucial for accurate dosing but doesn’t alter the peptide itself.

Our team generally advises against this. The plastic in syringes can sometimes cause peptides to adsorb or degrade over time. It is always best practice to draw each dose from the sterile glass vial immediately before use.

CJC-1295 without DAC (also known as Mod GRF 1-29) has a much shorter half-life. The version with DAC (Drug Affinity Complex) is chemically modified to bind to albumin in the blood, extending its half-life significantly. The reconstitution process is identical for both.

Absolutely not. The needle must remain sterile. Never let it touch your fingers, the countertop, or any non-sterile surface before piercing the sanitized vial stopper.

Lyophilized (unmixed) peptides are best stored in a refrigerator. For long-term storage (many months), they can be placed in a freezer to maximize their shelf life.

A small amount isn’t a major issue, but injecting a large volume of air can create positive pressure in the vacuum-sealed vial. This can make it difficult to draw an accurate dose or even cause the stopper to pop out.

While sterile saline can be used, it’s not ideal. Like sterile water, it contains no bacteriostatic agent. Bacteriostatic water remains our team’s top recommendation for safety and stability in a research setting.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

PROCEDURE

How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol

How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol The CJC-1295 and GHRP-2 blend represents a sophisticated combination of growth hormone-releasing compounds designed for advanced in vitro research applications. CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), functions synergistically with GHRP-2, a hexapeptide growth hormone secretagogue. This dual-component formulation enables researchers to investigate the complex interactions between GHRH and ghrelin receptor pathways in controlled laboratory environments. The lyophilised preparation ensures maximum stability and research-grade purity for precise experimental protocols. Required Laboratory Materials CJC-1295 + GHRP-2 blend vial (2mg/2mg lyophilised) Bacteriostatic water for injection (BWFI) or sterile water for injection Sterile syringes (1mL and 3mL capacities) Sterile needles (25-27 gauge, 1-inch length) Alcohol swabs (70% isopropanol) Laminar flow hood or sterile work environment Vial crimpers and sterile rubber stoppers Laboratory-grade refrigeration unit Precision analytical balance Sterile amber glass vials for aliquoting Pre-Reconstitution Laboratory Preparation Establish a sterile working environment within a laminar flow hood, ensuring all surfaces are thoroughly decontaminated with appropriate laboratory-grade disinfectants. Allow the lyophilised vial to equilibrate to room temperature for approximately 1…
DOSAGE SOURCE

Dosing Calculations Demystified

Let's get back to the math because accuracy here is just as important as the reconstitution technique. A miscalculation can invalidate your results just as surely as a denatured peptide. It seems complicated, but it breaks down into a simple, two-part process. Part 1: Find Your Concentration This is the same calculation we did earlier. The formula is:(Total Peptide in Vial in mcg) / (Total Volume of Diluent in mL) = Concentration in mcg/mL Let’s stick with our example: a 2mg vial of CJC 1295 and 2mL of bacteriostatic water. First, convert mg to mcg: 2mg * 1000 = 2000mcg Now, plug it into the formula: 2000mcg / 2mL = 1000mcg/mL So, every milliliter (mL) of your solution now contains 1000 micrograms (mcg) of CJC 1295. Part 2: Calculate Your Dose Volume Now you know your concentration, you can easily figure out how much liquid you need for your desired dose. Let's say your protocol calls for a 100mcg dose. The easiest way to think about this is using ratios, or you can use a simple formula:Desired Dose (mcg) / Concentration (mcg/mL) = Volume to Draw (mL) Using our example:100mcg / 1000mcg/mL = 0.1mL To administer a 100mcg dose, you need to draw 0.1mL of the solution. Translating mL to Units on a Syringe This is the final step that trips people up. Most researchers use U-100 insulin syringes for dosing because they are marked in 'units' and allow for very precise measurements. It's simple: a 1mL syringe is marked with 100 units. Therefore: 1.0mL = 100 units 0.5mL = 50 units 0.1m…
02

Question drills

Open a question for its connected answer.

01What If CJC-1295 Is Combined with an Anti-Resorptive Agent — Does It Amplify Bone Density Gains?+

Combining CJC-1295 with bisphosphonates or denosumab in preclinical models shows additive effects on BMD that exceed either agent alone. A 2017 study combining CJC-1295 (100 mcg/kg twice weekly) with zoledronic acid (single 0.1 mg/kg dose) in OVX rats increased lumbar spine BMD by 18% versus 9% with CJC-1295 alone and 11% with zoledronic acid alone. The mechanism: CJC-1295 increases bone formation, bisphosphonates suppress resorption, and the combination drives net positive bone balance. This combination approach is the basis for most current osteoporosis therapies and represents a logical design for fracture prevention research protocols.

SOURCE / realpeptides.co ↗
02What If I'm Stacking CJC-1295 with a GHRP Like Ipamorelin — Does Timing Change?+

Yes. Stacking changes the equation. GHRPs (growth hormone-releasing peptides like ipamorelin, GHRP-2, or hexarelin) work via a different receptor (ghrelin receptor) and can induce GH pulses independent of circadian timing. When stacking CJC-1295 with a GHRP, most research protocols dose both peptides together 2–3 times daily: upon waking, post-workout, and before bed. The GHRP creates the pulse; CJC-1295 amplifies it. For stacked protocols, nighttime dosing remains the largest dose, but the single-dose-before-bed rule no longer applies.

SOURCE / realpeptides.co ↗
03What if I use modified CJC-1295 (no DAC) instead of CJC-1295 with DAC?+

You're using a completely different compound with a completely different pharmacokinetic profile. Modified CJC-1295 without DAC has a half-life under 30 minutes. Identical to native GHRH. And requires multiple daily injections to maintain any GH response. The dosing protocols validated in CJC-1295 pharmacology studies do not apply to modified CJC-1295, and the sustained IGF-1 elevation documented in Phase II trials will not occur. If your research objective is to replicate the results from published CJC-1295 studies, you need the DAC-modified version.

SOURCE / realpeptides.co ↗
04What If I'm Already Taking Other Peptides Like BPC-157 or TB-500?+

Stacking peptides is common in research contexts, though direct interaction studies don't exist. BPC-157 and TB-500 act through different pathways (angiogenesis, actin regulation, inflammatory modulation) than CJC-1295's GH-IGF-1 axis. The mechanisms are theoretically complementary rather than redundant. If you're considering multi-peptide protocols, staging them (e.g., BPC-157 during weeks 1–4, CJC-1295 during weeks 3–12) may reduce the number of simultaneous variables and allow clearer assessment of individual contributions.

SOURCE / realpeptides.co ↗
05What If You've Been Running CJC-1295 Continuously for 12 Weeks Without an Off-Period?+

Cease administration immediately and implement a minimum six-week washout before restarting. Baseline IGF-1 testing at week zero of the washout and again at week six will confirm receptor recovery. You're looking for IGF-1 to return to pre-protocol baseline levels, indicating that endogenous GH pulsatility has normalized. Attempting to 'push through' diminished response by increasing dose escalates receptor internalization without restoring efficacy and compounds the recovery timeline required.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Why Sustained Elevation Matters in Research

So, why all the focus on sustaining GH levels? What's the scientific payoff? The potential applications are sprawling, touching nearly every aspect of physiology. When you create a protocol around CJC-1295 for sustained GH elevation, you're opening up avenues to study processes that are difficult to observe with short-acting compounds. One of the primary areas is cellular regeneration and repair. Growth hormone and IGF-1 are cornerstone signals for tissue maintenance. By maintaining elevated levels, researchers can study the accelerated repair of muscle, connective tissue, and even bone density over weeks and months. This has profound implications for Performance & Recovery Research, where understanding the limits of biological repair is the ultimate goal. We've seen this applied in studies looking at everything from tendon healing to recovery from induced muscular damage. Another significant field is metabolic health. GH has potent lipolytic effects—it encourages the body to break down stored fat for energy. A short pulse of GH has a transient effect on fat cells, but a sustained elevation can be studied for its long-term impact on body composition, insulin sensitivity, and overall metabolic rate. The research into CJC-1295 for sustained GH elevation directly informs our understanding of how the GH/IGF-1 axis governs energy partitioning. This is a central theme in many of the protocols designed using compounds from our Metabolic & Weight Research collection. And then there's the anti-aging and Longevity Research angle. It’s no secret that GH production declines precipitously with age (a phenomenon known as somatopause). This decline is linked to a host of age-related changes: loss of muscle mass (sarcopenia), increased fat mass, thinner skin, and reduced vitality. Research using CJC-1295 for sustained GH elevation allows scientists to investigate whether restoring GH and IGF-1 levels to more youthful ranges can mitigate or even reverse some of these biomarkers of aging in preclinical models. It's a difficult, often moving-target objective, but one with formidable implications for healthspan.

RESEARCH

Growth Hormone Deficiency Research

Clinical investigation of CJC-1295 in adult growth hormone deficiency (AGHD) represents a major research focus, as the peptide offers potential advantages over recombinant human growth hormone (rhGH) therapy. Unlike rhGH, which requires daily subcutaneous injections and directly replaces GH, CJC-1295 stimulates endogenous pulsatile GH secretion from functioning somatotrophs, potentially providing more physiologic hormone patterns. Studies in AGHD patients demonstrate significant increases in IGF-1 levels and improvements in body composition markers, with reductions in fat mass and increases in lean tissue comparable to rhGH therapy. The once-weekly dosing schedule offers substantial advantages in patient compliance and treatment burden. Ongoing research compares long-term outcomes, cost-effectiveness, and safety profiles between these therapeutic modalities https://pubmed.ncbi.nlm.nih.gov/18648019/.

05

Product & matchup locker

Linked catalog and comparison files.